Exit·Healthcare/Medical Devices·July 14, 2026
Leica Biosystems acquires StatLab Medical Products
The platform investment centers on a global developer and manufacturer of anatomical pathology products, with transaction terms undisclosed in the announcement.
Takeaways
- StatLab Medical Products is a Developer and manufacturer of anatomical pathology products for histology workflow laboratories.
- Audax Private Equity and Linden Capital Partners is exiting StatLab Medical Products through a sale to Leica Biosystems.
BuyerLeica Biosystems
TargetStatLab Medical Products
SponsorAudax Private Equity and Linden Capital Partners
TypeExit
IndustryHealthcare
Sub-sectorMedical Devices
Leica Biosystems acquired StatLab Medical Products, a global developer and manufacturer of anatomical pathology products.
StatLab has provided histology workflow products to anatomic pathology laboratories for more than 50 years.
Audax Private Equity and Linden Capital Partners are the sellers.
Daily PE deal brief
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.